Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Operating Margin: 2012-2024

Historic Operating Margin for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to 28.06%.

  • Amphastar Pharmaceuticals' Operating Margin fell 1664.00% to 13.20% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.73%, marking a year-over-year decrease of 888.00%. This contributed to the annual value of 28.06% for FY2024, which is 251.00% down from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Operating Margin of 28.06% as of FY2024, which was down 8.20% from 30.57% recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Operating Margin ranged from a high of 30.57% in FY2023 and a low of 3.13% during FY2020.
  • In the last 3 years, Amphastar Pharmaceuticals' Operating Margin had a median value of 28.06% in 2024 and averaged 26.73%.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Operating Margin spiked by 1,283bps in 2021, and later slumped by 251bps in 2024.
  • Yearly analysis of 5 years shows Amphastar Pharmaceuticals' Operating Margin stood at 3.13% in 2020, then spiked by 1,283bps to 15.96% in 2021, then surged by 558bps to 21.54% in 2022, then skyrocketed by 903bps to 30.57% in 2023, then slumped by 251bps to 28.06% in 2024.